Cargando…

Emerging Intrinsic Therapeutic Targets for Metastatic Breast Cancer

SIMPLE SUMMARY: Metastasis is the root cause of cancer death, responsible for roughly 90% of all cancer-related fatalities. Therefore, treating metastatic cancer is essential for optimal clinical management of these patients. Although there is currently no effective treatment for metastatic breast c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Jiawei, Goh, Eyleen L. K., He, Ji, Li, Yan, Fan, Zhimin, Yu, Zhigang, Yuan, Peng, Liu, Dong-Xu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10215321/ https://www.ncbi.nlm.nih.gov/pubmed/37237509 http://dx.doi.org/10.3390/biology12050697

Ejemplares similares

Diffuse Intrinsic Pontine Glioma: New Pathophysiological Insights and Emerging Therapeutic Targets
por: Johung, Tessa B., et al.
Publicado: (2017)

Therapeutic Implications for Intrinsic Phenotype Classification of Metastatic Castration-Resistant Prostate Cancer
por: Coleman, Ilsa M., et al.
Publicado: (2022)

Emerging Therapeutic Drugs in Metastatic Triple-Negative Breast Cancer
por: Cipriano, Élia, et al.
Publicado: (2021)

Potential therapeutic targets of triple-negative breast cancer based on its intrinsic subtype
por: Shao, Fangyuan, et al.
Publicado: (2017)

Glycoprotein non-metastatic b (GPNMB): A metastatic mediator and emerging therapeutic target in cancer
por: Maric, Gordana, et al.
Publicado: (2013)

Intrinsic control of axon regeneration
por: He, Zhigang
Publicado: (2010)

Alzheimer's Disease Blood Biomarkers Associated With Neuroinflammation as Therapeutic Targets for Early Personalized Intervention
por: Oh, Sher Li, et al.
Publicado: (2022)

Ferroptosis as an emerging therapeutic target in liver diseases
por: Lu, Yuzhen, et al.
Publicado: (2023)

ARID1A Mutation in Metastatic Breast Cancer: A Potential Therapeutic Target
por: Cheng, Xuan, et al.
Publicado: (2021)

PD-L1 tumor-intrinsic signaling and its therapeutic implication in triple-negative breast cancer
por: Chen, Chunhua, et al.
Publicado: (2021)

Decreased nonspecific adhesivity, receptor-targeted therapeutic nanoparticles for primary and metastatic breast cancer
por: Dancy, Jimena G., et al.
Publicado: (2020)

Emerging Role of ERBB2 in Targeted Therapy for Metastatic Colorectal Cancer: Signaling Pathways to Therapeutic Strategies
por: Wang, Nannan, et al.
Publicado: (2022)

beta1-integrin mediates myelin-associated glycoprotein signaling in neuronal growth cones
por: Goh, Eyleen LK, et al.
Publicado: (2008)

Non-Invasive Biomarkers for Early Detection of Breast Cancer
por: Li, Jiawei, et al.
Publicado: (2020)

Preventing metastatic emergence of breast cancer
por: Wells, Alan, et al.
Publicado: (2021)

Emerging Therapeutic Strategies for Diffuse Intrinsic Pontine Glioma: A Systematic Review
por: Farrukh, Shahrukh, et al.
Publicado: (2023)

NKG7 Is a T-cell–Intrinsic Therapeutic Target for Improving Antitumor Cytotoxicity and Cancer Immunotherapy
por: Wen, Ti, et al.
Publicado: (2022)

IL-13 receptors as possible therapeutic targets in diffuse intrinsic pontine glioma
por: Berlow, Noah E., et al.
Publicado: (2018)

Microvesicles as Emerging Biomarkers and Therapeutic Targets in Cardiometabolic Diseases
por: Chen, Yan, et al.
Publicado: (2018)

Current Therapeutic Strategies for Metastatic Triple-Negative Breast Cancer: From Pharmacists’ Perspective
por: Li, Shuanghe, et al.
Publicado: (2022)

Ginsenoside Rg3: Potential Molecular Targets and Therapeutic Indication in Metastatic Breast Cancer
por: Nakhjavani, Maryam, et al.
Publicado: (2019)

SHP2 is a multifunctional therapeutic target in drug resistant metastatic breast cancer
por: Chen, Hao, et al.
Publicado: (2020)

Neural Cells for Neurodegenerative Diseases in Clinical Trials
por: Fan, Yiping, et al.
Publicado: (2023)

PROteolysis TArgeting Chimeras (PROTACs) as emerging anticancer therapeutics
por: Khan, Sajid, et al.
Publicado: (2020)

Metastasis-associated fibroblasts: an emerging target for metastatic cancer
por: Wang, Zimu, et al.
Publicado: (2021)

Intrinsic subtypes and therapeutic decision-making in hormone receptor-positive/HER2-negative metastatic breast cancer with visceral crisis: A case report
por: Schettini, Francesco, et al.
Publicado: (2022)

Targeting of HER3 with Functional Cooperative miRNAs Enhances Therapeutic Activity in HER2-Overexpressing Breast Cancer Cells
por: Lyu, Hui, et al.
Publicado: (2018)

Integration of radiogenomic features for early prediction of pathological complete response in patients with triple-negative breast cancer and identification of potential therapeutic targets
por: Zhang, Ying, et al.
Publicado: (2022)

Extracellular Matrix: Emerging Roles and Potential Therapeutic Targets for Breast Cancer
por: Zhao, Yunchun, et al.
Publicado: (2021)

Emerging nanomedicine-based therapeutics for hematogenous metastatic cascade inhibition: Interfering with the crosstalk between “seed and soil”
por: Wu, Junyu, et al.
Publicado: (2021)

Endoplasmic Reticulum Stress: An Emerging Therapeutic Target for Intervertebral Disc Degeneration
por: Wang, Dong, et al.
Publicado: (2022)

Metastatic Breast Cancer: Review of Emerging Nanotherapeutics
por: Dissanayake, Ranga, et al.
Publicado: (2023)

Putting the BRK on breast cancer: From molecular target to therapeutics
por: Ang, Hui Li, et al.
Publicado: (2021)

The miR-5694/AF9/Snail Axis Provides Metastatic Advantages and a Therapeutic Target in Basal-like Breast Cancer
por: Tian, Xin, et al.
Publicado: (2021)

ICAM-1-suPAR-CD11b Axis Is a Novel Therapeutic Target for Metastatic Triple-Negative Breast Cancer
por: Li, Dong, et al.
Publicado: (2023)

Chemokines as possible therapeutic targets in metastatic melanoma
por: Basson, Charlise, et al.
Publicado: (2023)

BMI-1 is a potential therapeutic target in diffuse intrinsic pontine glioma
por: Kumar, Shiva Senthil, et al.
Publicado: (2017)

DIPG-03. THERAPEUTIC TARGETING OF TRANSCRIPTIONAL ELONGATION IN DIFFUSE INTRINSIC PONTINE GLIOMA
por: Katagi, Hiroaki, et al.
Publicado: (2020)

Targeting CD82/KAI1 for Precision Therapeutics in Surmounting Metastatic Potential in Breast Cancer
por: Viera, Maximillian, et al.
Publicado: (2021)

MicroRNA‐124: An emerging therapeutic target in cancer
por: Jia, Xinqi, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_bjhre6bmcjkjh34gf6h7falg57